Atypical hemolytic uremic syndrome: from diagnosis to treatment.

  title={Atypical hemolytic uremic syndrome: from diagnosis to treatment.},
  author={Massimo Franchini},
  journal={Clinical chemistry and laboratory medicine},
  volume={53 11},
Thrombotic microangiopathy (TMA) is a relatively rare condition but a medical urgency requiring immediate intervention to avoid irreversible organ damage or death. Symptoms on presentation include microangiopathic haemolytic anaemia, thrombocytopenia and organ damage. The most frequent direct causes of TMA are thrombotic thrombocytopenic purpura (TTP) and haemolytic uremic syndrome (HUS). The most common form of HUS is related to Shiga toxin producing Escherichia coli (STEC) infection while… CONTINUE READING